News Mylan finalises $465m deal with US government over EpiPen Mylan finalises rebate deal with US government.
News EU authorities accuse Teva of breaking competition rules Teva accused of "pay for delay" deal with Cephalon.
News Shire injunction blocks Roche's 'misleading' statements on h... Shire alleges trial info "unlawfully disparages" its product.
News Silence Therapeutics takes rival Alnylam to court in patent ... Silence claims late-stage drugs infringe patents.
News UK watchdog says MSD may have blocked Remicade biosimilars MSD may have abused dominant market position, says CMA.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
